October 17, 2020
By Prospection

Treatment persistence of subcutaneous TNF inhibitors among Australian patients with immune-mediated rheumatic disease (IMRD)

Introduction: To describe the persistence of treatment with subcutaneous tumor necrosis factor inhibitors (TNFi) adalimumab, etanercept, and golimumab in immune-mediated rheumatic dis- ease (rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis) by treatment sequence (first-line treatment, second-line or further lines of treatment).

Authors: Mustafa Acar, Prabhjot Juneja, Malcolm Handel
Open Access Rheumatology Research and reviews 2018:10

Download document

Related Resources

July 8, 2022

Real world use of antipsychotic medication

A recent publication using Prospection’s real-world data analytics shows, 1 in 5 Australian patients with schizophrenia [1] is medicated with older typical long acting injectable (LAI) antipsychotics. Schizophrenia is one of the top ten contributors to the global burden of...

November 2, 2020

Are high coronary risk patients missing out on lipid-lowering drugs in Australia?

To examine whether high coronary risk patients in Australia, where use of lipid-lowering drugs (LLD) is very high by international standards, are receiving LLD.

November 2, 2020

A retrospective review of the persistence of bDMARDs prescribed for the treatment of rheumatoid arthritis in the Australian population.

Aim: To describe the persistence of biologic disease modifying anti-rheumatic drugs (bDMARDs) in Australian rheumatoid arthritis (RA) patients, and assess the influence of methotrexate and other conventional DMARD (cDMARD) concomitant medications, and treatment line on bDMARD persistence and glucocorticoids usage.

October 21, 2020

Patterns of Antipsychotic Medication Prescribing in Australia.

Schizophrenia is a mental health disorder characterised by hallucinations, delusions and disorganised behaviour. The Australian pharmaceutical benefits scheme (PBS) reimburse a number of antipsychotic therapies, however, there is little known around the patterns of utilisation and the patient characteristics of...